CONDITION
Necrotising Meningoencephalitis (NME)
Necrotising meningoencephalitis is an inflammatory condition affecting the brain in which areas of tissue become damaged and die, primarily in certain small dog breeds. The inflammation targets both the membranes surrounding the brain and the brain tissue itself — in some breeds affecting the outer layers and deeper tissue of the cerebrum together, while in others the damage concentrates in different regions such as the brainstem or the connecting white matter pathways. Owners often arrive on this page because their dog has developed seizures, changes in behaviour, or difficulty with coordination or vision, typically over days to weeks. These signs can vary widely depending on which part of the brain is affected, and the same outward change may have many possible causes. This page explores what these signs may point to, what is understood about the underlying process, how the condition is investigated through imaging and other tests, and what approaches are used to manage inflammation and support quality of life.
Why this matters now
Necrotising meningoencephalitis tends to appear in young to middle-aged dogs, often between six months and seven years of age, though the window varies. Certain smaller breeds are affected more frequently, including Pugs, Maltese, Chihuahuas, Shih Tzus, and Yorkshire Terriers, though the condition is occasionally seen in other breeds or mixed-breed dogs. No clear environmental, nutritional, or lifestyle trigger has been identified, and the pattern of occurrence suggests a possible genetic or immune-mediated component in predisposed lines.
The condition typically progresses over weeks to months, though the pace and pattern can differ markedly between individuals. Some dogs develop signs that worsen steadily, while others may experience periods of apparent stability punctuated by sudden deterioration. The course is generally progressive, meaning that signs tend to accumulate or intensify over time, though the rate of change and the specific combination of signs observed depend on which regions of the brain are affected and how the inflammation evolves.
Signals & patterns
Early signals
Seizures appearing for the first time
A dog may experience a seizure without any prior history, often as the first outward sign that something has changed. The seizure itself can take various forms—rhythmic jerking, paddling, loss of awareness, or collapse—and may be brief or prolonged.
Altered responsiveness or awareness
An owner may notice that their dog seems less engaged with the household, slower to respond to their name, or less interested in familiar routines. This can manifest as staring into space, delayed reactions, or a general sense that the dog is not quite present in the way they once were.
Changes in gait or coordination
Some dogs begin to move differently—stumbling, swaying, or appearing unsteady when walking. The change may be subtle at first, perhaps more noticeable on stairs or uneven ground, and can affect one side of the body more than the other.
Head pressing or circling
A dog may press its head against walls, furniture, or the owner's body, or begin walking in tight circles in one direction. These behaviours often reflect dysfunction in the forebrain and can appear alongside other cognitive or motor changes.
Behavioural shifts
Personality or temperament may shift in ways that feel out of character—increased anxiety, withdrawal, restlessness, or confusion in familiar settings. An owner may describe their dog as seeming lost or uncertain, even in their own home.
Later signals
Worsening or clustering seizures
Seizures may become more frequent, last longer, or occur in clusters where several episodes happen within a short window of time. This shift often signals progression of the underlying inflammation.
Severe incoordination or inability to stand
As the condition advances, some dogs lose the ability to walk steadily or maintain balance, and may spend increasing amounts of time lying down. Weakness or loss of motor control can affect multiple limbs.
Marked cognitive decline
An owner may observe profound confusion, failure to recognise familiar people or places, or a near-complete withdrawal from interaction. The dog may appear profoundly altered in awareness or responsiveness.
Vision loss or abnormal eye movements
Some dogs develop blindness that is not explained by changes in the eye itself, or exhibit repetitive, involuntary eye movements. These signs reflect involvement of the visual pathways or structures in the brainstem.
Click to read about the biological mechanisms
How this is usually investigated
Investigation typically begins with a detailed history and neurological examination to identify which parts of the nervous system are affected and how quickly signs have developed. Because the condition can resemble other causes of brain inflammation, infection, or structural disease, tests are used to narrow the range of possibilities and to look for changes that support the diagnosis. Advanced imaging of the brain and analysis of cerebrospinal fluid are central to the investigation, though a definitive diagnosis often requires examination of brain tissue itself.
Magnetic resonance imaging (MRI)
Cerebrospinal fluid analysis
Chemistry panel
Complete blood count
Histopathology
Options & trade-offs
Management is directed at suppressing the immune response that drives inflammation and at controlling signs such as seizures or changes in behaviour. Treatment is tailored to the individual, taking into account the severity and speed of progression, the presence of complications, and what is practical for the owner and dog over time. Different combinations of medication may be tried as the condition evolves, and adjustments are often needed based on response and tolerability.
Immunosuppressive therapy with corticosteroids
Corticosteroids such as prednisolone are used to reduce immune activity and inflammation within the brain. Doses are typically started at a higher level and then adjusted based on clinical response. The aim is to slow or halt progression of tissue damage while managing side effects such as increased thirst, appetite, and susceptibility to infection.
Trade-offs: Corticosteroids can produce noticeable improvements in some dogs but may not stop progression entirely, particularly if tissue damage is already extensive. Long-term use can lead to weight gain, muscle weakness, and changes in behaviour, and some dogs develop complications such as urinary-tract infections or gastrointestinal upset.
Combination immunosuppression with additional agents
Drugs such as ciclosporin, leflunomide, or mycophenolate may be added to corticosteroid therapy to provide stronger or more sustained immune suppression. These combinations are often considered when corticosteroids alone do not control signs adequately or when side effects from high-dose corticosteroids become limiting. Each agent has a different mechanism of action and requires monitoring for specific side effects.
Trade-offs: Adding further immunosuppressive drugs increases complexity and cost, and response varies between individuals. Some combinations require regular blood monitoring to check for effects on organ function or blood-cell production, and there is an increased risk of opportunistic infection when immune activity is heavily suppressed.
Anticonvulsant medication
If seizures are part of the clinical picture, anticonvulsant drugs such as phenobarbital or levetiracetam may be used to reduce seizure frequency and severity. These medications work by altering electrical activity in the brain and are typically continued for the duration of the condition.
Trade-offs: Anticonvulsants can be effective at controlling seizures but do not address the underlying inflammation. Some drugs require blood-level monitoring and can cause sedation or changes in liver function over time, and seizures may still occur despite treatment if brain damage continues to progress.
Supportive care and environmental adjustment
As the condition affects movement, awareness, or coordination, practical adjustments at home can help maintain comfort and safety. This may include confining activity to smaller spaces to reduce risk of injury, providing non-slip surfaces, and adapting feeding or toileting arrangements. Monitoring for changes in behaviour or new signs allows treatment to be adjusted in a timely manner.
Trade-offs: Supportive measures do not alter the course of the disease but can improve day-to-day quality of life and reduce distress for both dog and owner. The degree of adjustment needed tends to increase as the condition progresses, and ongoing care can be demanding.
Common misconceptions
"Necrotising encephalitis is caused by an infection that can be treated with antibiotics."
The inflammation in necrotising encephalitis appears to be driven by the immune system attacking the brain's own tissue rather than by bacteria, viruses, or other infectious agents. Antibiotics do not target the underlying immune process, and treatment focuses instead on suppressing immune activity with corticosteroids or other immunosuppressive drugs.
"All dogs with this condition will deteriorate rapidly regardless of treatment."
The speed and pattern of progression vary considerably between individuals. Some dogs show meaningful stabilisation or temporary improvement with immunosuppressive therapy, and the length of time that quality of life remains acceptable differs from one case to another. The response to treatment and the ultimate course of the condition cannot be predicted with certainty at the outset.
"Brain inflammation always causes seizures, so a dog without seizures cannot have necrotising encephalitis."
Seizures are common in dogs with necrotising encephalitis but are not present in every case. Other signs—such as changes in behaviour, loss of learned behaviours, head tilt, circling, or reduced coordination—may appear instead or in addition, depending on which parts of the brain are affected. The absence of seizures does not exclude the diagnosis.
Related conditions
Granulomatous Meningoencephalomyelitis (GME)
Granulomatous meningoencephalomyelitis shares many clinical features with necrotising meningoencephalitis—both are inflammatory conditions of the brain and spinal cord that can cause seizures, behaviour changes, and coordination difficulties. The two conditions can be difficult to distinguish without tissue examination, as both produce similar signs and respond to similar approaches, though the pattern of inflammation differs at a cellular level.
Steroid-Responsive Meningitis-Arteritis (SRMA)
Steroid-responsive meningitis-arteritis is another inflammatory condition affecting the membranes surrounding the brain and spinal cord, and forms part of the group of immune-mediated central nervous system diseases that clinicians often consider together when a dog presents with neurological signs of sudden onset. The conditions can overlap in their presentation, though steroid-responsive meningitis-arteritis tends to cause neck pain and stiffness more prominently than necrotising meningoencephalitis.
Epilepsy in Dogs
Epilepsy in dogs often features as part of the differential diagnosis when a dog presents with seizures, one of the most common signs of necrotising meningoencephalitis. While epilepsy describes recurrent seizures without an identified structural brain disease, necrotising meningoencephalitis produces seizures through active inflammation and tissue damage, and the distinction between the two may require imaging and cerebrospinal fluid analysis.
Brain Tumours
Brain tumours can produce similar outward signs to necrotising meningoencephalitis—seizures, altered behaviour, difficulty with movement or vision—because both involve space-occupying or tissue-damaging processes within the skull. Imaging and sometimes cerebrospinal fluid analysis help distinguish inflammatory disease from tumour growth, though in some cases the two may need to be considered together when planning investigation.
Hepatic Encephalopathy
Hepatic encephalopathy can cause changes in behaviour, awareness, and sometimes seizures through a completely different mechanism—accumulation of metabolic toxins rather than brain inflammation—but may be considered as part of the investigation when a dog presents with neurological signs. Blood testing typically helps distinguish liver-related changes from primary brain disease early in the diagnostic process.
Understanding how the condition has been investigated and what the findings mean can be a useful foundation for conversations about treatment options and realistic expectations over time. Some owners find it helpful to explore related topics within cognitive and behavioural health, particularly if their dog's signs overlap with other causes of altered awareness or seizures. Observing how signs change day to day, and noting what makes daily life easier or harder, often informs the next round of discussions about care.